MONDAY, Nov. 10, 2025 (HealthDay News) — Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million people estimated to be living with ...

Let’s jump in: Multiple sclerosis is an autoimmune disease affecting the brain and spinal cord. The condition occurs when your immune system does not recognize myelin, the fatty white layer coating ...

An international expert panel has developed consensus guidelines to help clinicians navigate multiple sclerosis (MS) diagnosis in atypical populations — specifically children and older adults. Here's ...

Neurofilament light chain is a promising noninvasive biomarker for multiple sclerosis (MS), but lacks disease specificity due to other neurological causes. Apolipoprotein levels are negatively ...

Glenn Wylie, DPhil is director of the Rocco Ortenzio Neuroimaging Center and recipient of a National Multiple Sclerosis Society grant. East Hanover, NJ — April 9, 2024 —The National Multiple Sclerosis ...

The biggest difference between ocrelizumab and the recently approved ofatumumab is that ofatumumab can be taken at home for relapsing forms of multiple sclerosis (MS), explained Patricia K. Coyle, MD.

An estimated 2.3 million individuals are living with multiple sclerosis (MS) worldwide. Approximately half of all individuals with MS experience changes in cognition such as impaired concentration, ...